Advanced Heart Failure & Transplant Cardiology — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: AHF/T, advanced HF, transplant cardiology, "HF." Organ system: the heart, specifically end-stage and failing hearts, plus the machines and transplanted organs that replace them.

Sub-subspecialty of Cardiology, a further fellowship after the Cardiovascular Disease fellowship (itself a subspecialty of Internal Medicine).

The 30-second version

Advanced Heart Failure & Transplant Cardiology is the corner of cardiology that takes care of the sickest hearts in the building, and, by reputation and by the numbers, the one you choose for the work rather than the paycheck. These are the cardiologists who run heart-transplant and LVAD (mechanical circulatory support) programs, manage cardiogenic shock in the ICU, optimize guideline-directed drug therapy in clinic, and follow a single patient for years, sometimes a decade-plus, from the first "your heart is failing" conversation through a pump, a transplant, lifelong immunosuppression, and, often, honest end-of-life care. It is the most cognitive, most longitudinal, highest-acuity, and lowest-procedure branch of adult cardiology.

Here is the paradox that defines it, and you should hear it up front: AHF/T requires the most training of the adult-cardiology tracks and manages the highest acuity, yet it is consistently the lowest-paid cardiology subspecialty, often earning less than the general cardiologists its trainees started out with, and hundreds of thousands less than the interventionalists and electrophysiologists down the hall. It is also, remarkably, an under-subscribed field: about four in ten of its fellowship slots go unfilled every year even as demand for HF specialists climbs. That combination is the whole personality of the field: extra training, top acuity, bottom pay, empty seats, and it selects hard for people who mean it.

Quick dashboard (details and sources below)
Training after med school 7 years: IM residency (3) + Cardiovascular Disease fellowship (3) + Advanced HF & Transplant fellowship (1) 1
Total from college start ~15 years (4 undergrad + 4 med school + 3 IM + 3 cardiology + 1 AHF/T)
Competitiveness (as a cardiology sub-subspecialty) Low / under-subscribed — 59.8% fill, ~0.69 applicants per position (NRMP SMS, 2026) 2 ⟳
Typical full-time pay ~$560,000–$620,000 total comp — the lowest of the cardiology subspecialties 34 ⟳
Pay vs. the rest of cardiology $275k/yr below interventional ($838k); below EP, echo/nuclear, and even general cardiology 3 ⟳
Lifestyle Inpatient/ICU-heavy, frequent disruptive call (organ offers, LVAD alarms, shock transfers) — schedule control low-to-moderate
Burnout Cardiology 43.5% against a 41.9% all-physician baseline (AMA 2025); high call + high acuity + no pay cushion 5 ⟳
% women 42.4% of AHF/T fellows (ACGME AY2024-25) — roughly double interventional (18.1%) and EP (13.7%) 5 ⟳
DO / IMG accessibility DO 15.8% and IMGs ~36% of positions filled in the 2026 match — an under-filled field leans on IMGs 2 ⟳

What they actually do

Advanced heart-failure and transplant cardiologists manage end-stage and advanced heart failure across its entire arc, from the outpatient clinic where they titrate guideline-directed medical therapy and try to keep people out of the hospital, to the CICU where they stabilize cardiogenic shock, to the transplant program where they decide who goes on the waitlist, manage immunosuppression after a new heart, and run the durable LVAD / mechanical circulatory support (MCS) program.6 The core skill is complex cognitive management of the sickest cardiac patients over time: reading hemodynamics, matching a failing physiology to the right drug, pump, or transplant, and knowing when the honest move is palliation rather than escalation.

It is a low-procedure field by cardiology standards. Where interventionalists live in the cath lab and electrophysiologists in the EP lab, the AHF/T cardiologist's day is dominated by inpatient rounds, ICU decisions, clinic visits, and coordination, with the cath lab used mainly for right-heart catheterization, hemodynamic assessment, and increasingly percutaneous MCS.67 That is precisely why the field is described as "the internist's cardiology": it rewards broad internal-medicine breadth and cognitive depth over procedural volume.7

Representative work: heart-transplant candidacy evaluation and waitlist management · post-transplant immunosuppression and rejection surveillance · durable LVAD / MCS candidacy and long-term device management · cardiogenic-shock and CICU care · right-heart catheterization and invasive hemodynamics · inpatient advanced-HF consult service · outpatient GDMT optimization, remote monitoring, and readmission prevention · goals-of-care and palliative-care integration.67

A day in the life: it bends to the census. On service, you round on a CICU and ward full of the most fragile cardiac patients in the hospital, from shock to fresh transplants to LVAD complications, where small management errors carry large consequences. An organ offer, a donor run, an LVAD alarm, or a shock transfer can rearrange the day (or the night) at any hour, because none of it respects a 9-to-5.6 Off service, the rhythm shifts to advanced-HF clinic and follow-up, the same patients, sometimes for years. Academic/employed models often block the calendar into weeks "on service" versus clinic/research weeks, which buys back some predictability.6

The training path & time to completion

This is a sub-subspecialty, so the road is long and the chain matters. Here is the whole thing:

Medical school (4 yrs) → Internal Medicine residency (3 yrs) → Cardiovascular Disease fellowship (3 yrs) → Advanced Heart Failure & Transplant Cardiology fellowship (1 yr) → board-eligible with ABIM in AHF/T.1

  • Internal Medicine residency (3 yrs): the base residency, entered straight from med school (ACGME- or AOA-accredited).1
  • Cardiovascular Disease fellowship (3 yrs): the subspecialty step, after which you are a general cardiologist, and could stop here and practice.1
  • Advanced HF & Transplant fellowship (1 yr): the sub-subspecialty step. It is a 12-month ACGME-accredited fellowship that "must function as an integral part of an ACGME-accredited fellowship program in cardiovascular disease," and applicants should ideally have completed a three-year CV disease program before starting.1
  • Application: AHF/T has moved to a synchronized ERAS + NRMP match (the Medicine & Pediatric Specialties / Specialties Matching Service).8
  • Board: ABIM Advanced Heart Failure and Transplant Cardiology certification, which requires prior ABIM certification in Cardiovascular Disease plus completion of the 1-year AHF/T fellowship.9 ⟳
  • Total from the start of college: ~15 years (4 undergrad + 4 med school + 3 IM + 3 cardiology + 1 AHF/T) = 7 years after med school.1

The honest framing for a premed: to reach AHF/T you first complete an entire competitive specialty (cardiology) and could earn a full cardiologist's income at year 6, and then choose to spend a seventh year training for a job that, on average, pays less. That is a real and unusual feature of this field, not a footnote (see Compensation).

How competitive is it?

By the numbers, AHF/T is one of the least competitive final steps in all of cardiology, though not because it's easy to get to (you've already finished IM and a competitive cardiology fellowship), but because there are far more fellowship seats than applicants. This is genuinely counterintuitive.

NRMP Specialties Matching Service, 2026 appointment year:2 ⟳

  • 74 programs · 127 positions offered · 76 filled → 51 unfilled (59.8% fill rate).
  • 88 applicants → ~0.69 applicants per position.
  • Filled positions by type: US MD 35 · US DO 12 · US-citizen IMG 7 · non-US IMG 20 · Canadian 2, which is all 76. IMGs filled 27 of those 76 seats (~36%), because an under-subscribed field leans on international graduates to staff itself.

The fill rate moved a long way this cycle, and both directions matter. It has run 57.0%, 55.9%, 56.6%, 48.0% and now 59.8% across 2022 to 2026 — so the 2025 collapse the older version of this page described was the outlier, not the trend, and the field is roughly back where it sat three years ago.2 ⟳

This isn't a one-year fluke. The ACC reported a ~38% vacancy rate persisting for roughly four consecutive years (as of 2023), and peer-reviewed analyses in 2025 documented the worsening unfilled-position trend.101112 ⟳

What it means for you: most well-qualified cardiology fellows who want AHF/T can match. The scarce, competitive part of this path is getting into cardiology in the first place, not adding the HF year. The reason the seats sit empty is the compensation-vs-training math below, which is exactly what makes this a "choose-it-for-the-work" field.

Compensation — the robust version

The headline: AHF/T is consistently the lowest-paid adult cardiology subspecialty, despite the most training and the highest acuity. This is well-documented across the two best survey families and is not a data artifact.3413

Why it happens, because the mechanism matters. Cardiology pay is still overwhelmingly driven by wRVU production (billable procedure/visit volume), and AHF/T is a cognitive, inpatient- and consult-heavy, low-procedure field. HF cardiologists generate nearly two-thirds of their wRVUs from E&M encounters (office/inpatient visits) rather than procedures.13 Their value, in keeping the sickest patients alive, running transplant and LVAD programs, and preventing readmissions, shows up as institutional prestige, program accreditation, and downstream revenue (the transplants, devices, and imaging billed by other cardiologists and surgeons), not in the HF doctor's own procedure log. The interventionalist bills high-RVU procedures; the HF doctor bills mostly visits. In an RVU pay system, that gap becomes a paycheck gap.13

National number. The most recent authoritative surveys put AHF/T median total compensation in the ~$560,000–$620,000 band:34

  • AMGA 2026 survey (2025 data): $561,947. Down 2.6% year-over-year, and the lowest of the cardiology subspecialties AMGA breaks out. Its wRVUs fell −19.7% that year.3 ⟳
  • MedAxiom/ACC 2024 survey (2023 data): $620,000 (integrated and employed), still the lowest listed cardiology subspecialty; private-practice AHF/T was reported as insufficient data (the subgroup is too small).4 ⟳
  • Historical anchor: MedAxiom (2018 data) reported $441,845 per FTE, "over 10% lower" than general and non-invasive cardiology at the time, so the field has risen in absolute terms but stayed at the bottom.13

The paradox, quantified (AMGA 2026 on 2025 data), as median total comp by cardiology subspecialty:3 ⟳

  • Interventional cardiology: $837,619 (↑4.7%)
  • Electrophysiology: $831,413 (↑8.4%)
  • Echo lab & nuclear cardiology: $728,165 (↑18.6%)
  • General cardiology: $648,852 (↑5.4%)
  • Advanced heart failure & transplant: $561,947 (↓2.6%), the lowest of them.

So AHF/T earns roughly $275,000/yr less than interventional cardiology despite comparable-or-longer training and higher patient acuity, and it's the only one of these that fell while the rest rose.3

The spread. No large-sample public percentile table exists for this specific sub-subspecialty (small, overwhelmingly academic workforce), so the spread comes from lower-confidence aggregators, useful for shape rather than authority:

  • SalaryDr (2026): a median of $600,000 across a range of $400k–$605k, on about five self-reported submissions. The site also prints a 25th percentile of $418,000 and a 75th percentile of $600,000, but a percentile drawn from five submissions orders five people rather than describing a distribution, and the 75th sits exactly on the median because of it.14 ⟳
  • Realistic synthesis: ~$400k (entry/academic, low end) to ~$700k+ (senior, high-volume employed transplant center or program-director role), median clustering $560k–$620k. Nothing published supports more precision than that.34 ⟳

Academic vs. employed: the dominant split here. AHF/T is disproportionately academic/institutional, because transplant and durable LVAD/MCS programs concentrate at large academic and quaternary referral centers (the reason private-practice data is too sparse to report).15 Academic settings pay meaningfully less: SalaryDr's panel shows academic average ~$409,000 vs. hospital-employed ~$601,667, a ~$193k gap, though that is two subgroups carved out of the same five submissions and is worth no more than the sample it rests on.14 The general MedAxiom pattern amplifies this: integrated and employed cardiologists topped $700,000 vs. private practice $588,479 in 2024 data, "the largest gap in over five years."16 ⟳

Geography. No AHF/T-specific regional table is published; using all-cardiology as a proxy (MedAxiom 2023 data): South ~$711,000 (highest) · West ~$656,000 · Midwest / Northeast ~$648,000.4 The catch specific to this field: because AHF/T jobs cluster at big-city academic transplant centers, which sit in the lower-paying coastal and academic geographies, many AHF/T physicians are working in exactly the markets that pay cardiology the least. ⟳

Employment models / what you're actually paid for. Comp tracks the job because the work is program- and inpatient-centric, not procedure-centric:6

  1. Transplant and durable MCS program roles (quaternary academic), with the highest institutional value, often with program-director stipends and hospital support beyond personal RVUs; this is where the higher (~$600k–$700k+) numbers come from.
  2. Inpatient-heavy consultative HF (CICU, cardiogenic-shock teams, high-acuity consults), RVU-poor relative to time and acuity; central to the low-pay paradox.
  3. Outpatient HF clinic and GDMT optimization, E&M-dominant, lowest RVU intensity, most exposed to the wRVU model; value-based/readmission incentives can add comp but aren't yet dominant.

Panel/access pressure is intense cardiology-wide (~2,000 patients per physician FTE and worsening access).16 ⟳

The trend that colors all of it. Cardiology overall hit all-time highs in 2024–2025 (full-time median $694,954, MedAxiom 2025), driven by invasive, interventional, and EP work, while AHF/T stagnated or fell.16 AMGA's own analyst has warned that ~half of recent comp increases are "supported by ongoing growth in wRVU production" and this "is not sustainable," a red flag aimed squarely at a low-RVU field like this one.3 The gap between AHF/T and procedural cardiology is widening, not closing. ⟳

Lifestyle

Lifestyle: demanding and inpatient-heavy; schedule control low-to-moderate. AHF/T carries the highest acuity in cardiology outside the cath lab and CICU: cardiogenic shock, mechanical circulatory support, and post-transplant patients, the sickest and most fragile cardiac population, where small errors carry large consequences.6 The logistics run at all hours: organ offers, donor runs, LVAD alarms, and shock transfers don't respect a schedule, so call is frequent and genuinely disruptive.6 The setting mix is real, spanning CICU and ICU, wards, outpatient advanced-HF clinic, and the cath lab for hemodynamics and percutaneous MCS, which many find a draw, though the inpatient/ICU weighting is heavy compared with imaging-heavy cardiology. Your day bends to the census, but block scheduling (weeks on service vs. clinic/research) in academic models gives some predictability, and it is generally described as less lifestyle-destroying than some surgical transplant roles.6

Lifestyle rating: 2/5. High acuity, frequent disruptive call, and census-driven days mean limited control, partially offset by academic block scheduling.

Wellbeing — the part to take seriously

The honest tension. Cardiology broadly reports meaningful burnout. The AMA's 2025 Organizational Biopsy, the largest free primary instrument, puts cardiology at 43.5% against a 41.9% all-physician baseline, so the field sits just above the middle rather than at either extreme.5 ⟳ A narrative review of cardiology burnout, working from ACC and Medscape data on their own separate baselines, names EHR/documentation burden, bureaucracy, and workload as the top drivers and links burnout to ~4x lower job satisfaction and >3x higher career-choice regret.17 AHF/T's specific version of the strain is high call + high acuity + emotionally heavy work (you lose patients), without the compensation cushion the procedural fields enjoy.6

And yet "would choose again" runs paradoxically high for those who self-select in. The pull is the depth of longitudinal relationships, following a patient for years through LVAD, transplant, and beyond, plus the visceral reward of pulling the sickest patients back from the edge. It's the classic "meaning over money" wellbeing profile.6 Career longevity is helped by that meaning and by ferocious, durable demand (job security is excellent); it's challenged by the emotional load of mortality, the intensity of call, and the pay-vs-effort mismatch that can wear on people mid-career.6

Who's in the field (demographics)

  • Women: 42.4% of the 92 AHF/T fellows on duty in AY2024-25, roughly double the female share of interventional cardiology (18.1% of 365) and electrophysiology (13.7% of 350).5 An earlier fellowship study, on 2022–2023 data, put the three at 35.3%, 16.2% and 14.2%, so all three have risen and the relationship has held.18 An ACC trainee survey found 45.5% of those interested in AHF/T were women (vs. 32.1% of those not interested), suggesting the field disproportionately attracts women relative to cardiology overall.10 For context, women are ~16% of practicing cardiologists broadly (AAMC 2022), so AHF/T sits well above its parent field.19 ⟳
  • DO: rising and no longer scarce. DOs took 12 of the 76 positions filled in the 2026 match (15.8%), against 8.3% of fellows in the 2022–2023 study and 6 of 61 filled positions (~9.8%) in 2025. The fellows-on-duty census is the lagging figure of the three, at 7 of 92 (7.6%) in AY2024-25.2185 ⟳
  • IMG: a meaningful and growing entry point. IMGs (US-citizen plus non-US) took 27 of the 76 positions filled in the 2026 match (~36%), and are 38 of the 92 fellows on duty in AY2024-25 (41.3%); the 2022–2023 study found 27.3% non-US graduates. An under-filled field leans on international graduates to staff itself.2185 ⟳
  • URiM (Black, Hispanic/Latino, etc.): limited data. The main diversity study explicitly did not collect race/ethnicity data for these fellowships, and no reliable AHF/T-specific URiM breakdown was found, so none is estimated here.18

Culture, personality & the online stereotypes

Who gravitates here (a read on reputation rather than a rule; plenty of AHF/T cardiologists don't fit it): cognitive-cardiology lovers who find deep satisfaction in physiology, hemodynamics, and complex medical decision-making rather than in procedures; people drawn to long-term relationships with patients and families; those genuinely comfortable sitting with very sick patients, uncertainty, and mortality, including honest goals-of-care and palliative conversations; and, notably, many who are explicitly mission-driven and consciously choose meaning and continuity over the higher income of interventional or EP. As always, plenty of people in the field do not fit any single mold.67

The stereotypes. Community caricatures rather than facts, each with an unfair edge:

  • "The mission-driven idealist who does it for love, not money." There's a real kernel here, since the field selects hard for intrinsic motivation, but it flattens people who also just love the medicine of it rather than only the sacrifice.
  • "The internist's cardiology." Meant half as a compliment, half as a dig ("the cardiologist who didn't want to do procedures"). Reality: managing shock, transplants, and MCS is a genuine high-acuity expertise no procedural subspecialty owns.
  • "Why do an extra fellowship to earn less?" The single most-repeated framing online. Real as economics, but it treats the field purely as an ROI calculation and misses why anyone chooses it.
  • "Transplant-and-VAD only." Undersells a field that now spans cardiogenic shock/critical care, percutaneous MCS, cardio-oncology overlap, amyloid/HCM therapeutics, and palliative integration.7

What people say online (synthesized and paraphrased, not quotes): across trainee and physician forums the single most-discussed theme is the pay-vs-demand paradox: demand for HF specialists is enormous and rising, the fellowship increasingly goes unfilled, and yet the extra training year doesn't reliably raise pay above general cardiology and often lands below the procedural tracks; community members openly puzzle over why a field this needed pays so little for so much training. The recurring framing is that this is a "choose-it-for-the-work" field, and people who are honest with themselves say the money math doesn't justify it, so it selects for intrinsic motivation. Job security and geographic flexibility are described as outstanding (you can work almost anywhere; programs recruit aggressively). And there's a consistent caution: don't do it if you need procedures for identity or income, or if repeated patient deaths would grind you down.6

Voices from the field. Paraphrased from public writing, with links to the originals:

  • A cardiology fellow writing for the ACC's For the FITs documents that the AHF/T match filled only 61 of 127 positions (48%) in the 2025 appointment year, with just 28% of programs filling, and names the compensation gap directly: advanced-HF training "typically does not lead to additional compensation" despite call at all hours and critically ill patients, arguing for flexible pathways and pay aligned to clinical demand.20
  • A narrative review of burnout in cardiology quantifies the problem (~27% ACC / ~43% Medscape), names EHR/bureaucracy/workload as leading drivers, and links burnout to sharply lower job satisfaction and higher career-choice regret.17
  • A Journal of Cardiac Failure piece frames "the advanced heart failure workforce crisis" as a widening mismatch between surging clinical demand and shrinking recruitment into the pipeline.11
  • An American Journal of Cardiology analysis documents the worsening trend of unfilled positions in the AHF/T match.12

Why people choose it / why people leave

Why choose it: you love cognitive, physiology-driven medicine and complex longitudinal management more than procedures · you want the deepest, longest patient relationships in cardiology, in years-long arcs through LVAD and transplant · you want to save the sickest cardiac patients and are energized, not depleted, by high-stakes ICU work · ironclad job security and geographic freedom (demand vastly exceeds supply) · meaning and mission genuinely outweigh income in your personal calculus.6

Why leave or avoid it: compensation is at the bottom of cardiology despite the most training · frequent, disruptive call and transplant/MCS logistics at all hours, with low schedule control · emotionally heavy, since recurrent patient deaths and goals-of-care conversations are the job rather than the exception · little procedural identity or the RVU-driven income upside of interventional/EP · a wRVU-dependent pay model that surveys flag as unsustainable for a low-procedure field.36

Best fit if: you're the internist-at-heart who fell in love with cardiac physiology · you want to own a patient's whole story over years · you're calm around mortality and shock · you'd genuinely rather do the meaningful work than chase the top of the pay scale.6

Not for you if: you need procedures for professional identity or income · you want predictable hours and light call · you're ground down by patient death · you'd resent doing an extra fellowship year to earn the same or less than your general-cardiology co-fellows.6

The FLI angle — Advanced HF & Transplant for first-gen, low-income & immigrant students

Where AHF/T fits FLI realities well:

  • Reachable via a well-trodden path with no pedigree gatekeeping at the last step. The chain is IM residency → general cardiology fellowship → 1 AHF/T year, and because the AHF/T match is now frequently unfilled, it is among the least competitive final steps in cardiology to secure. The hard, competitive part is getting into cardiology; the HF year itself is wide open.26
  • Exceptional job security and geographic flexibility. Demand for advanced-HF specialists is high and growing (a documented workforce crisis), so you can find work almost anywhere, which is genuinely valuable if you're supporting family or can't chase scarce jobs across the country.611
  • Still life-changing money in absolute terms. Even at the "low" end of cardiology, total comp is well into the mid-six figures (~$560k–$620k), transformative for someone from a low-income background, even if it trails the procedural subspecialties.34
  • Deep, durable meaning for those motivated by service to very sick, often under-resourced patients, and a field where women and IMGs are better represented than in most of cardiology.18

Risks to name honestly:

  • The pure ROI points elsewhere. This is the lowest-paying cardiology sub-subspecialty despite the most training and the highest acuity. If you took on this path partly to maximize earning power and debt payoff, the money math favors interventional, EP, or simply stopping at general cardiology, which pays more for one fewer year of training.36
  • The seventh year has a real opportunity cost. You could be earning a full cardiologist's salary during the AHF/T year instead of a fellow's stipend, and then step into a job that pays less. Go in with eyes open that the extra year buys meaning and job security, not a bigger paycheck.6
  • The lifestyle cost is real. Frequent disruptive call, ICU intensity, and recurrent patient death are the daily texture of the job, not the exception.

Bottom line: AHF/T is one of the clearest "choose-it-for-the-work" fields in medicine, with outstanding job security, deep meaning, high absolute income, and an unusually open final step, bundled with the honest catch that it asks the most training and the highest acuity for the lowest cardiology pay. If the work itself pulls you, it is reachable and secure. If the paycheck is the point, this isn't the branch of cardiology that maximizes it.

Subspecialties, overlaps & where the field is growing

AHF/T is itself the terminal fellowship, but the work increasingly overlaps with several adjacent areas, and the field is quietly broadening well beyond "transplants and VADs":7

  • Cardiac critical care / cardiogenic shock. CICU leadership and shock teams; heavy overlap with AHF/T's inpatient work.
  • Percutaneous mechanical circulatory support (MCS). A growing procedural-adjacent piece of the field.
  • Cardio-oncology. Managing heart failure caused by cancer therapies.
  • Amyloid and HCM therapeutics. Newer disease-specific drug management.
  • Palliative-care integration. The HFSA has issued consensus recommendations on integrating palliative care into heart-failure practice.7

Fun facts

  • The field that can't fill its own class: despite a nationwide HF-specialist shortage, the AHF/T match has not filled more than 60% of its positions in five years, and in 2025 it filled fewer than half (61 of 127). A rare "in-demand but under-recruited" specialty.1220
  • The only cardiology fellowship where the extra year can lower your pay relative to the procedural tracks, the crux of its "you do it for the patients" reputation.320
  • Part cardiologist, part device manager, part intensivist: AHF/T physicians manage machines (LVADs and other MCS) that take over the heart's pumping.7
  • Among the longest continuous doctor–patient relationships in all of medicine: the same physician may follow a patient for a decade-plus, from first advanced-HF clinic visit through VAD, transplant, and lifelong immunosuppression.7
  • It's "the internist's cardiology". More than any other cardiac subspecialty, it rewards broad internal-medicine breadth and cognitive management over procedural volume.7

Sources

Footnotes

  1. Training pathway (IM 3 + Cardiovascular Disease fellowship 3 + AHF/T 1 = 7 yrs after med school), 12-month ACGME-accredited AHF/T fellowship as an integral part of an ACGME CV disease program. ACGME Program Requirements for Advanced Heart Failure and Transplant Cardiology, 2025. https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/159_advancedheartfailuretransplantcardiology_2025_reformatted.pdf (2025). ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  2. AHF/T match data — NRMP Specialties Matching Service, 2026 appointment year: 74 programs, 127 positions offered, 76 filled (59.8%), 88 applicants (~0.69 applicants/position); filled by type US MD 35 / DO 12 / US-IMG 7 / non-US IMG 20 / Canadian 2, which sums to the 76 filled. Corrected 2026-08-17: the Canadian-graduate column was dropped from the breakdown in both this footnote and the body, so five categories were printed as four and summed to 74 against 76 filled. Every figure was right; the list just did not add up on the page. Five-year fill: 57.0% (2022), 55.9% (2023), 56.6% (2024), 48.0% (2025), 59.8% (2026). NRMP, Results and Data: Specialties Matching Service 2026 Appointment Year, February 2026, Tables 1A–1D and the Advanced Heart Failure trend page. https://www.nrmp.org/wp-content/uploads/2026/02/SMS_Results_and_Data_Report2026.pdf (2026). The figures this page previously carried — 61 filled, ~48%, 64 applicants — are the 2025 appointment year, correct for that cycle and labeled as 2026. See also NRMP Medicine & Pediatric Specialties MRS Report 2025: https://www.nrmp.org/wp-content/uploads/2025/12/2025-Medicine-and-Pediatric-Specialties-MRS-Report.pdf (2025). Corrected 2026-08-17: the quick dashboard's DO/IMG row was still on the 2025 cycle — "DO ~8–10% of fellows; IMGs ~43%" — while the competitiveness section three screens below already ran on 2026, and the two disagreed in the direction that matters most to a reader weighing accessibility. Table 2 of the 2026 report gives 12 of 76 filled positions to US DOs (15.8%) and 27 to IMGs (~36%). The 2025 pair is kept in the demographics section, where the year is stated beside it. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  3. AMGA 2026 survey (2025 data) — AHF/T median total comp $561,947 (↓2.6%, lowest cardiology subspecialty; wRVUs −19.7%); interventional $837,619, EP $831,413, echo/nuclear $728,165, general cardiology $648,852; sustainability warning (Fred Horton). Cardiovascular Business, "Compensation, salaries in cardiology, electrophysiology, heart surgery." https://cardiovascularbusiness.com/topics/healthcare-management/cardiologist-salary/compensation-salaries-cardiology-electrophysiology-heart-surgery (2026). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13

  4. MedAxiom/ACC 2024 survey (2023 data) — AHF/T ("Heart Failure") $620,000 integrated/employed (lowest listed cardiology subspecialty; private practice insufficient data); general cardiology $635,000; regional all-cardiology (South $711k highest, West $656k, Midwest/Northeast ~$648k). Cardiovascular Business, "Cardiologist compensation hits all-time high." https://cardiovascularbusiness.com/topics/healthcare-management/cardiologist-salary/cardiologist-compensation-hits-all-time-high (2024). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  5. Burnout instrument and the fellow census. Burnout: cardiology 43.5% against a 41.9% all-physician baseline. AMA, These 9 physician specialties report highest burnout rates (2025 Organizational Biopsy, ~19,000 physicians across 38 states). https://www.ama-assn.org/practice-management/physician-health/these-9-physician-specialties-report-highest-burnout-rates (2025). Fellow census: ACGME Data Resource Book, Academic Year 2024-2025 — Table C.21 gives AHF/T 92 fellows across 84 programs, 39 women (42.4%), against interventional cardiology 365 fellows / 66 women (18.1%) and clinical cardiac electrophysiology 350 fellows / 48 women (13.7%); Table C.15 gives AHF/T 45 US LCME graduates (48.9%), 38 IMGs (41.3%), 7 DOs (7.6%) and 2 Canadian graduates (2.2%). https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf (AY2024-25). ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  6. Lifestyle, wellbeing, culture, decision guide, employment models, and "meaning over money"/would-choose-again profile. Synthesized from Medscape lifestyle/compensation reports (2024/2025), ACC/HFSA commentary, physician-writing platforms (KevinMD, Doximity Op-Med), and paraphrased community sentiment (r/cardiology, r/medicalschool, SDN). Sentiment is a paraphrased read of online reputation, not fact. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16 ↩17 ↩18 ↩19 ↩20 ↩21 ↩22

  7. Field scope, "internist's cardiology," longitudinal relationships, LVAD/MCS device management, and broadening into shock/critical care, percutaneous MCS, cardio-oncology, amyloid/HCM, and palliative integration (HFSA consensus). Synthesized from HFSA/ACC commentary and community sentiment as above. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10

  8. Move to synchronized ERAS + NRMP match. HFSA, "AHFTC Fellowship to Move to ERAS and NRMP Application with Synchronized Match System." https://hfsa.org/advanced-heart-failure-and-transplant-cardiology-ahftc-fellowship-move-eras-and-nrmp-application (accessed 2026). ↩

  9. Board certification — ABIM Advanced Heart Failure and Transplant Cardiology (requires prior ABIM Cardiovascular Disease certification + 1-yr AHF/T fellowship). ABIM, Advanced Heart Failure and Transplant Cardiology Policies. https://www.abim.org/certification/policies/internal-medicine-subspecialty-policies/advanced-heart-failure-transplant-cardiology/ (accessed 2026). ↩

  10. Persistent ~38% vacancy over ~4 years and women's interest signal (45.5% of interested trainees women). American College of Cardiology, "What Factors Influence Interest in Advanced Heart Failure/Transplant Cardiology Fellowship?", Oct 2023. https://www.acc.org/latest-in-cardiology/articles/2023/10/17/13/07/what-factors-influence-interest-in-advanced-heart-failure-transplant-cardiology-fellowship (2023). ↩ ↩2

  11. Advanced-HF workforce crisis (demand vs. recruitment mismatch). "The Advanced Heart Failure Workforce Crisis: A Path Forward," Journal of Cardiac Failure (2025). https://onlinejcf.com/article/S1071-9164(25)00992-3/abstract (2025). ↩ ↩2 ↩3

  12. Worsening unfilled-position trend in the AHF/T match. "Increasing Rate of Unfilled Training Positions in the Advanced Heart Failure and Transplant Cardiology Match," American Journal of Cardiology (2025). https://www.ajconline.org/article/S0002-9149(25)00511-9/abstract (2025). ↩ ↩2 ↩3

  13. Compensation mechanism — HF cardiologists earn ~2/3 of wRVUs from E&M, ~2% of the cardiology workforce, historically ~$441,845/FTE (2018 data, "over 10% lower" than general/non-invasive). MedAxiom, "Heart Failure Cardiologists Earn Less, Produce Less than Other Cardiologists." https://info.medaxiom.com/blog/heart-failure-cardiologists-earn-less-produce-less-than-other-cardiologists (2018 data). ↩ ↩2 ↩3 ↩4

  14. Spread and academic-vs-employed, on a sample of about five self-reported submissions — median $600,000, 25th $418k, 75th $600k, range $400k–$605k; academic avg $409,000 vs. hospital-employed $601,667. SalaryDr, Heart Failure. https://www.salarydr.com/specialty/cardiology/heart-failure (2026). SalaryDr panel size: n=5. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. Corrected 2026-08-17: the spread above used to carry a second bullet, a ZipRecruiter average of $357,482 for "Advanced Heart Failure And Transplant Cardiology," with its own footnote warning readers not to use it as a headline. ZipRecruiter is an excluded source on this site, and three sibling cardiology and orthopedics profiles removed their ZipRecruiter ranges outright on 2026-08-13 rather than relabeling them, because a job-board average is evidence about advertised postings rather than about earnings. The bullet and its footnote are gone. The paragraph's point, that the shape of the spread rests on low-confidence aggregators, survives without it. Corrected 2026-08-17: the body presented the 25th and 75th percentiles as a percentile ladder, which five submissions cannot support — the 75th lands exactly on the median and the top of the range sits $5,000 above it. Both figures are still printed, now labeled for what they are, and the academic-versus-employed gap is labeled as two subgroups of the same five submissions rather than as a second finding. ↩ ↩2

  15. AHF/T is disproportionately academic/institutional (transplant + durable LVAD/MCS programs concentrate at large academic/quaternary UNOS-certified centers; private-practice data too sparse to report). Per MedAxiom "insufficient data" note for private-practice HF, ref 4, and comp.md synthesis. ↩

  16. Employment-model gap and cardiology all-time highs — integrated/employed >$700,000 vs. private practice $588,479 (2024 data, "largest gap in over five years"); full-time cardiologist median $694,954 (all-time high); ~2,000 patients per physician FTE. MedAxiom 2025 survey via Cardiac Wire (https://cardiacwire.com/medaxiom-report-cardiologist-compensation-soars-patient-access-struggles/) and Business Wire (https://www.businesswire.com/news/home/20251015425867/en/New-Data-on-Cardiology-Compensation-and-Production-Highlights-Solutions-for-Workforce-Shortages) (2025). ↩ ↩2 ↩3

  17. Burnout in cardiology (~27% ACC / ~43% Medscape; EHR/bureaucracy/workload drivers; ~4x lower satisfaction, >3x higher career-choice regret). Brilakis ES et al., "Burnout in Cardiology: A Narrative Review," Journal of Invasive Cardiology (HMP Global Learning Network). https://www.hmpgloballearningnetwork.com/site/jic/original-contribution/burnout-cardiology-narrative-review (accessed 2026). Corrected 2026-08-17: the dashboard and the wellbeing section led with this review's "~27% (ACC) to ~43% (Medscape)" pair, which sets two instruments with different all-physician baselines side by side as though they bracketed one range. Under this site's ordering the AMA's 2025 Organizational Biopsy publishes a cardiology row and is the primary, so it now leads; see 5. The review's own pair stays where the review itself is being described, since the drivers and the satisfaction and regret findings are what it is cited for. ↩ ↩2

  18. AHF/T fellow demographics (2022–2023) — 35.3% women vs. interventional 16.2% / EP 14.2%; 8.3% DO; 27.3% non-US graduates; race/ethnicity not collected. "Updates on Diversity Among Cardiology-Related Fellowships," PMC10646983. https://pmc.ncbi.nlm.nih.gov/articles/PMC10646983/ (2022–2023 data). Corrected 2026-08-17: this study was the page's only demographic source and its figures were two years stale in the dashboard and the demographics list. The ACGME AY2024-25 census now leads on all three sex shares and on the DO and IMG shares of fellows on duty; see 5. The study's own figures are retained beside them because the direction of travel is part of the point, and its finding that race and ethnicity were not collected still stands as the reason no URiM figure appears here. ↩ ↩2 ↩3 ↩4 ↩5

  19. Women ~16% of practicing cardiologists (cardiovascular disease), 2022. AAMC Physician Specialty Data Report / "Women are changing the face of medicine in America." https://www.aamc.org/news/what-s-your-specialty-new-data-show-choices-america-s-doctors-gender-race-and-age (2022 data). ↩

  20. Stephanie Golob, MD (cardiology fellow, NYU Langone), ACC For the FITs, "Heart Failure Fellowship and the Failure of Recruitment" (June 2025) — 61 of 127 filled (48%), 28% of programs filled, which NRMP's own trend table places in the 2025 appointment year rather than 2024; advanced-HF training "typically does not lead to additional compensation." https://www.acc.org/latest-in-cardiology/articles/2025/06/01/01/for-the-fits-heart-failure-fellowship (2025). ↩ ↩2 ↩3

Researched with AI assistance and reviewed by hand. How this site is made